| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 8, 2025 |
| Accession Number: | 0001213900-25-029597 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 8, 2025 |
| Accession Number: | 0001213900-25-029597 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/6/2023 | $1.75 | Equal-Weight | Morgan Stanley |
| 12/16/2022 | Neutral | JP Morgan | |
| 8/17/2022 | $2.80 | Neutral | Credit Suisse |
| 1/10/2022 | $5.00 | Hold → Buy | Lake Street |
| 1/10/2022 | Hold → Buy | Lake Street | |
| 11/16/2021 | Buy → Hold | Cross Research | |
| 10/8/2021 | Perform | Oppenheimer | |
| 6/25/2021 | $14.00 | Neutral | Credit Suisse |